Guiyang Hao
-
- Radiopharmaceutical Chemistry and Applications 25
- Medical Imaging Techniques and Applications 11
- Monoclonal and Polyclonal Antibodies Research 6
- Biomaterials top 5%
- Oncology top 10%
- Peptidase Inhibition and Analysis 4
-
- Cancer, Hypoxia, and Metabolism 5
-
- Nanoplatforms for cancer theranostics 7
-
- Nanocluster Synthesis and Applications 4
-
- Advanced biosensing and bioanalysis techniques 4
- Journals
- Proceedings of the National Academy of Sciences (1 paper)Angewandte Chemie International Edition (2 papers)PLoS ONE (2 papers)
- Partner nations
- United StatesChinaTaiwan
In The Last Decade
Guiyang Hao
50 papers receiving 1.6k citations
Peers
Comparison fields: 5 of 107
- Radiology, Nuclear Medicine and Imaging 522
- Biomaterials 195
- Oncology 308
- Cancer Research 150
- Pulmonary and Respiratory Medicine 288
Countries citing papers authored by Guiyang Hao
This map shows the geographic impact of Guiyang Hao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Guiyang Hao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Guiyang Hao more than expected).
Fields of papers citing papers by Guiyang Hao
This network shows the impact of papers produced by Guiyang Hao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Guiyang Hao. The network helps show where Guiyang Hao may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Guiyang Hao, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 0 | |
| 2 | 2022 | 54 | |
| 3 | 2022 | 18 | |
| 4 | 2022 | 10 | |
| 5 | 2021 | 11 | |
| 6 | 2021 | 44 | |
| 7 | 2019 | 56 | |
| 8 | 2019 | 62 | |
| 9 | 2018 | 186 | |
| 10 | 2014 | 4 | |
| 11 | 2014 | 10 | |
| 12 | 2014 | 34 | |
| 13 | 2013 | 21 | |
| 14 | 2013 | 14 | |
| 15 | 2012 | 187 | |
| 16 | 2011 | 27 | |
| 17 | 2010 | 17 | |
| 18 | 2010 | 18 | |
| 19 | 2010 | 68 | |
| 20 | Synthesis, 99Tcm-labeled and biodistribution study of γ-thioureidopropyl germanium sesquisulfide | 2002 | 1 |
About Guiyang Hao
Guiyang Hao is a scholar working on Radiology, Nuclear Medicine and Imaging, Oncology and Cancer Research, having authored 52 papers that have together received 1.7k indexed citations. Recurring topics across this work include Radiopharmaceutical Chemistry and Applications (25 papers), Medical Imaging Techniques and Applications (11 papers), Nanoplatforms for cancer theranostics (7 papers), Monoclonal and Polyclonal Antibodies Research (6 papers), Cancer, Hypoxia, and Metabolism (5 papers), Nanocluster Synthesis and Applications (4 papers), Peptidase Inhibition and Analysis (4 papers) and Advanced biosensing and bioanalysis techniques (4 papers). The work is most often cited by research in Radiology, Nuclear Medicine and Imaging (522 citations), Biomaterials (195 citations) and Oncology (308 citations). Guiyang Hao has collaborated with scholars based in United States, China and Taiwan. Frequent co-authors include Xiankai Sun, Orhan K. Öz, Jer‐Tsong Hsieh, Jie Zheng, Jinbin Liu, Mengxiao Yu, Shasha Sun, Chen Zhou, Michael A. Long and P. K. Thomas. Their work appears in journals such as Proceedings of the National Academy of Sciences, Angewandte Chemie International Edition and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.